TVTX FY 2019 Earnings — Travere Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TVTXTravere Therapeutics, Inc.

$3B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$175M+6.8% YoY

Gross Profit

$170M97.0% margin

Operating Income

-$100M-56.9% margin

Net Income

-$146M-83.5% margin

EPS (Diluted)

$-3.46

Cash Flow

Operating Cash Flow

-$58M

Free Cash Flow

-$74M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$605M

Total Liabilities

$384M

Stockholders' Equity

$221M

Cash & Equivalents

$62M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$175M	$164M	+6.8%
Gross Profit	$170M	$159M	+7.2%
Operating Income	-$100M	-$80M	-24.7%
Net Income	-$146M	-$103M	-42.6%